Drugmakers Must Face FTC's AndroGel Antitrust Suit
A Georgia federal judge largely refused Thursday to let a group of pharmaceutical companies out of a nearly decade-old antitrust multidistrict litigation from the Federal Trade Commission and private parties alleging...To view the full article, register now.
Already a subscriber? Click here to view full article